Entropy Technologies LP Buys 5,409 Shares of Dolby Laboratories $DLB

Entropy Technologies LP grew its holdings in Dolby Laboratories (NYSE:DLB) by 43.4% during the 2nd quarter, Holdings Channel reports. The fund owned 17,870 shares of the electronics maker’s stock after buying an additional 5,409 shares during the period. Entropy Technologies LP’s holdings in Dolby Laboratories were worth $1,327,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also added to or reduced their stakes in the company. MAI Capital Management boosted its position in shares of Dolby Laboratories by 87.1% in the first quarter. MAI Capital Management now owns 348 shares of the electronics maker’s stock worth $28,000 after purchasing an additional 162 shares during the period. Cheviot Value Management LLC purchased a new position in shares of Dolby Laboratories during the 1st quarter valued at $27,000. Caitong International Asset Management Co. Ltd purchased a new position in shares of Dolby Laboratories during the 1st quarter valued at $29,000. Allworth Financial LP boosted its holdings in Dolby Laboratories by 590.4% in the 2nd quarter. Allworth Financial LP now owns 504 shares of the electronics maker’s stock worth $37,000 after buying an additional 431 shares during the period. Finally, Ameritas Advisory Services LLC purchased a new stake in Dolby Laboratories in the 2nd quarter worth $48,000. Hedge funds and other institutional investors own 58.56% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have recently commented on DLB. Rosenblatt Securities lowered their price objective on Dolby Laboratories from $95.00 to $85.00 and set a “buy” rating on the stock in a research report on Wednesday. Weiss Ratings reissued a “hold (c-)” rating on shares of Dolby Laboratories in a report on Thursday, November 13th. Barrington Research cut their price objective on shares of Dolby Laboratories from $100.00 to $95.00 and set an “outperform” rating for the company in a report on Wednesday. Wall Street Zen cut shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a research report on Saturday. Finally, Robert W. Baird initiated coverage on shares of Dolby Laboratories in a report on Friday, September 5th. They issued a “neutral” rating and a $74.00 target price on the stock. Three investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Dolby Laboratories presently has a consensus rating of “Moderate Buy” and a consensus price target of $92.00.

Insider Activity at Dolby Laboratories

In related news, CEO Kevin J. Yeaman sold 25,000 shares of Dolby Laboratories stock in a transaction dated Tuesday, October 14th. The stock was sold at an average price of $68.87, for a total value of $1,721,750.00. Following the completion of the transaction, the chief executive officer owned 114,725 shares in the company, valued at approximately $7,901,110.75. This trade represents a 17.89% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 38.39% of the company’s stock.

Dolby Laboratories Price Performance

NYSE:DLB opened at $67.52 on Friday. The company has a market cap of $6.47 billion, a price-to-earnings ratio of 24.73 and a beta of 0.97. Dolby Laboratories has a 1 year low of $64.02 and a 1 year high of $89.66. The stock’s 50 day simple moving average is $68.59 and its two-hundred day simple moving average is $72.35.

Dolby Laboratories (NYSE:DLB) last posted its earnings results on Tuesday, November 18th. The electronics maker reported $0.99 earnings per share for the quarter, beating analysts’ consensus estimates of $0.70 by $0.29. Dolby Laboratories had a net margin of 19.62% and a return on equity of 11.52%. The firm had revenue of $307.02 million during the quarter, compared to analyst estimates of $305.76 million. During the same period last year, the firm posted $0.61 earnings per share. Dolby Laboratories’s revenue for the quarter was up .7% compared to the same quarter last year. Dolby Laboratories has set its FY 2026 guidance at 4.190-4.340 EPS. Q1 2026 guidance at 0.790-0.940 EPS. As a group, analysts anticipate that Dolby Laboratories will post 2.94 EPS for the current year.

Dolby Laboratories Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, December 10th. Stockholders of record on Tuesday, December 2nd will be given a dividend of $0.36 per share. The ex-dividend date is Tuesday, December 2nd. This represents a $1.44 annualized dividend and a dividend yield of 2.1%. This is a positive change from Dolby Laboratories’s previous quarterly dividend of $0.33. Dolby Laboratories’s dividend payout ratio is currently 54.75%.

About Dolby Laboratories

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.